Research on Quality Issues and Optimization Path of Clinical Trials Based on Management Experience and Literature Evidence

Cao Yongcang, Cao Xun, Ge Jing

Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (8) : 892-897.

PDF(956 KB)
PDF(956 KB)
Chinese Pharmaceutical Affairs ›› 2025, Vol. 39 ›› Issue (8) : 892-897. DOI: 10.16153/j.1002-7777.2025-05-0014
Quality Management

Research on Quality Issues and Optimization Path of Clinical Trials Based on Management Experience and Literature Evidence

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2025, 39(8): 892-897 https://doi.org/10.16153/j.1002-7777.2025-05-0014

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(956 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉